Buy Suncorp shares for strong returns and big dividend yields: Goldman Sachs

Big returns could be on the cards for this insurance giant's shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Suncorp Group Ltd (ASX: SUN) shares could offer investors a nice mix of capital gains and income.

That's the view of analysts at Goldman Sachs, which are feeling bullish on the insurance giant.

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.

Image source: Getty Images

Why is Goldman saying about Suncorp shares?

According to a note released this morning, the broker has retained its buy rating and $14.53 price target on the company's shares.

Based on the current Suncorp share price of $13.01, this implies potential upside of 11.7% for investors over the next 12 months.

In addition, as mentioned above, its shares are also expected to provide investors with a nice source of income in the coming years.

Goldman is forecasting fully franked dividends of 79 cents per share in both FY 2023 and FY 2024. This will mean attractive yields of 6.1% for investors in both financial years.

Why is the broker bullish?

Goldman believes that the company is well-placed to benefit from favourable trading conditions. It commented:

We are favourably disposed to Suncorp, noting in large part the tailwinds that exist in the general insurance market – i.e., very strong renewal premium rate increases and the benefit of higher investment yields. We think the strong rate momentum that SUN is getting should likely offset volume pressures as they optimise their risk exposures in certain portfolios such as home but also likely policy lapses / buy downs.

And while the broker sees some margin pressures in the near term, it feels price increases will offset much of this. It adds:

We think that while SUN's underlying margin is likely to face pressure into FY24 from higher reinsurance costs again, increased perils allowances, AMA contract renegotiation and possibly lower reserve release assumptions, we note that SUN is putting through significant price increases to reflect these pressures with the benefits flowing through with a lag. Further, we note that we could start to see more meaningful benefits from underlying claims inflation abating into FY24E. Separate to our thesis, we also see possible catalysts on the horizon for SUN including capital return post the bank sale and the possibility of a whole of account quota share arrangement similar to IAG.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Broker Notes

Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Morgans has updated its ratings and 12-month price targets on these 3 ASX 200 shares.

Read more »